Evidence map›Paper›PMID 41777287›Full record

ArticleHelminthologia2025

Green synthesis of zinc oxide (ZnO) nanoparticles using aqueous leaves extracts of

S S Eldera, S Aldawsari, M Abou El-Nour

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Helminthologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

S S ElderaPhysics Department, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
S AldawsariPhysics Department, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
M Abou El-NourZoology Department, Faculty of Science, Al-Azhar University, Nasr City 11884, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schistosomiasis continues to affect the health and quality of life of millions worldwide. Schistosomiasis is ranked as the second most significant targeted tropical disease after malaria. Praziquantel (PZQ) is the sole medication authorized by the World Health Organization (WHO) for the treatment of schistosomiasis. The sole drug has led to the development of parasite resistance. Consequently, the pursuit of novel alternatives has been the objective of numerous researchers. The use of nanotechnology in the treatment of schistosomiasis is of paramount importance for mitigating the adverse effects associated with chemotherapy. This study evaluated the effects of green-synthesized zinc oxide nanoparticles by

Indexed as

Artemisia annuaBiosynthesisCharacterizationPlant extractSchistosoma mansoniZinc oxide nanoparticles

Identifiers

PMID41777287
PMCPMC12951014

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.